Concomitantly, Michel and colleagues performed a systematic evaluation of the FOXP3+ immune infiltration and MMR deficiency, revealing that MMRd/MSI-High (MSI-H)-deficient colorectal cancer displayed increased FOXP3-positive cells. This evidence concerns the gene FOXP3 and mismatch repair cancer syndrome 1.